Lee's Pharmaceutical Holdings Limited

HKEX:0950.HK

1.18 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q22009 Q2
Revenue 270.363270.363256.154256.154196.966387.016324.416324.75313.77368.335300.91283.142322.674337.326283.732272.984305.045306.334324.593282.941270.701299.202285.818281.905258.762275.01248.55226.2231.168248.924224.191225.538211.985232.262247.58230.323265.813246.679236.502206.214184.777177.407186.322148.447146.19132.362145.892109.889129.66105.40290.94473.67960.67843.578
Cost of Revenue 136.939136.939113.923113.92388.012144.693120.764108.924142.282120.085106.77590.731117.277127.27698.63192.466107.7107.75111.26393.94497.019104.746100.13989.35180.0990.23579.06376.7360.16779.44154.85167.12763.51370.39973.36466.7177.56475.87272.64858.60148.76448.39454.92441.61842.06837.62141.98531.82439.01326.07423.4119.35517.81511.735
Gross Profit 133.424133.424142.232142.232108.954242.323203.652215.826171.488248.25194.135192.411205.397210.05185.101180.518197.345198.584213.33188.997173.682194.456185.679192.554178.672184.775169.487149.47171.001169.483169.34158.411148.472161.863174.216163.613188.249170.807163.854147.613136.013129.013131.398106.829104.12294.741103.90778.06590.64779.32867.53454.32442.86331.843
Gross Profit Ratio 0.4930.4930.5550.5550.5530.6260.6280.6650.5470.6740.6450.680.6370.6230.6520.6610.6470.6480.6570.6680.6420.650.650.6830.690.6720.6820.6610.740.6810.7550.7020.70.6970.7040.710.7080.6920.6930.7160.7360.7270.7050.720.7120.7160.7120.710.6990.7530.7430.7370.7060.731
Reseach & Development Expenses 44.77744.77724.39924.3992.03250.26354.95661.63463.38767.54965.03447.86560.22167.91349.79225.36833.48837.64544.37434.43857.36431.96132.39731.44927.64320.42116.0920.90319.72715.5317.86418.47118.3446.4989.8212.4135.749.80812.4979.91913.224.6419.9374.4646.9123.732.9122.753.7972.481.9413.6171.5721.048
General & Administrative Expenses 49.01449.01445.29245.29229.08558.25353.79657.27980.98792.07765.3358.87160.59565.99361.33849.79574.05960.33154.70849.9965.43243.49235.92944.07344.76133.18640.00341.26839.35638.52633.59235.0379.48627.50440.14935.17133.0925.3417.96622.94919.60221.50318.27519.13118.19911.35122.93510.55711.7669.0098.4597.8567.5324.969
Selling & Marketing Expenses 78.68378.68373.46673.46677.34692.90694.24981.966107.57694.74591.54972.56989.56468.24756.20765.92980.10363.59359.70648.35769.05550.51839.5762.59761.01158.72351.69442.72241.27852.50459.01451.42957.28558.83567.92172.42479.53781.05981.11267.49462.47658.16855.26746.93945.97147.79344.87640.87243.45141.91539.91831.15316.19712.059
SG&A 128.189128.189118.906118.906106.431151.159148.045139.245188.563186.822156.879131.44150.159134.24117.545115.724154.162123.924114.41498.347134.48794.0175.499106.67105.77291.90991.69783.9980.63491.0392.60686.46666.77186.339108.07107.595112.627106.39999.07890.44382.07879.67173.54266.0764.1759.14467.81151.42955.21750.92448.37739.00923.72917.028
Other Expenses 0000-1.559-0.623-2.658-10.25248.111-10.6482,116.97425.21265.6184.030.1231.06732.086.276-91.320.314258.6671.0750.4065.5910.2060.491.9690.4341.0540.2940.0549.308-6.6123.6951.3612.269-7.4344.2731.1485.5950.2071.5240.9361.791-6.4774.202-1.6585.102-5.4911.886-1.965-7.644-1.3060.009
Operating Expenses 128.901128.901126.491126.491106.904200.799200.343190.627300.061243.723216.079171.845198.605195.798164.115134.74252.681163.353158.131127.172201.199118.162102.057133.514119.805107.98104.76101.87498.57375.11984.436104.93778.49992.837117.89120.008109.653116.207111.575100.36292.3784.31283.47970.53465.16362.87469.06554.17953.52353.40448.35334.98223.99518.085
Operating Income 1.8191.81916.20316.203-33.52654.26620.31735.503-176.38711.8572,095.74747.36616.82220.25964.80650.03665.90345.023-33.74164.22215.1889.69774.97487.08573.08479.56169.64754.53673.71484.1577.7862.78268.14375.74897.71444.8266.34658.87353.42752.84647.19546.22548.85538.08634.46336.06934.84228.98832.4627.8119.18119.34218.86813.758
Operating Income Ratio 0.0070.0070.0630.063-0.170.140.0630.109-0.5620.0326.9650.1670.0520.060.2280.1830.2160.147-0.1040.2270.7950.30.2620.3090.2820.2890.280.2410.3190.3380.3470.2780.3210.3260.3950.1950.250.2390.2260.2560.2550.2610.2620.2570.2360.2730.2390.2640.250.2640.2110.2630.3110.316
Total Other Income Expenses Net -0.02-0.02-2.609-2.609-2.653-2.021-2.033-1.992-1.569-1.814-2.299-3.535-4.791-3.511-4.94-4.644-5.84721.735-93.02522.332-5.77319.95515.73116.371-4.91114.3621.95713.495-5.768-3.583-2.98511.372-2.33913.37450.4069.3180.9290.603-2.459-2.412-2.053-1.659-0.268-0.291-0.322-0.363-0.258-0.249-0.209-0.099-0.201-0.532-0.539-0.173
Income Before Tax 1.7991.79913.59413.594-36.17952.24518.28433.511-177.95610.0432,093.44843.83112.03116.74859.86645.39260.05640.198-37.82660.458209.40784.75370.25981.96568.17373.2465.60550.6167.94680.56774.79559.29665.80470.45475.85541.82267.27559.47650.96850.43445.14244.56648.58737.79534.14135.70634.58428.73932.25127.71118.9818.8118.32913.585
Income Before Tax Ratio 0.0070.0070.0530.053-0.1840.1350.0560.103-0.5670.0276.9570.1550.0370.050.2110.1660.1970.131-0.1170.2140.7740.2830.2460.2910.2630.2660.2640.2240.2940.3240.3340.2630.310.3030.3060.1820.2530.2410.2160.2450.2440.2510.2610.2550.2340.270.2370.2620.2490.2630.2090.2550.3020.312
Income Tax Expense 2.2792.2793.143.14-23.31720.6311.86712.8467.146-1.041-4.0987.47513.18712.99917.92311.39424.8695.22412.60616.8424.0617.98615.79118.78420.97214.49410.5688.65515.24413.69411.17210.0885.6413.26516.3735.6612.72611.4017.5529.6897.186.9977.2345.6766.1954.834.954.1295.1954.0612.6381.8342.7581.301
Net Income 0.2910.2918.0598.059-12.86234.2246.41720.307-185.10213.8432,114.15241.0487.3125.02457.08639.89645.20942.05-8.6646.954220.79971.69955.59370.17845.66561.82478.6946.3857.77372.81168.31153.10764.44361.58362.5840.44656.29149.46644.97342.138.86537.84841.44432.3128.15731.17829.86324.60926.92223.62816.46216.89415.57112.284
Net Income Ratio 0.0010.0010.0310.031-0.0650.0880.020.063-0.590.0387.0260.1450.0230.0740.2010.1460.1480.137-0.0270.1660.8160.240.1950.2490.1760.2250.3170.2050.250.2930.3050.2350.3040.2650.2530.1760.2120.2010.190.2040.210.2130.2220.2180.1930.2360.2050.2240.2080.2240.1810.2290.2570.282
EPS 0.0010.0010.0140.014-0.0220.0580.0110.035-0.310.0243.590.070.0120.0430.0970.0680.0590.071-0.0150.0790.370.120.0940.120.0770.10.130.0790.0980.120.120.0910.110.110.110.0730.10.0910.0830.0780.0720.0710.0790.0620.0540.060.0620.0520.0570.050.0350.0360.0350.03
EPS Diluted 0.0010.0010.0140.014-0.0220.0580.0110.035-0.310.0243.590.070.0120.0430.0970.0680.0590.071-0.0150.0790.370.120.0930.120.0770.10.130.0780.0980.120.120.090.110.10.110.0720.10.0890.080.0750.0720.0680.0750.0580.0540.0590.060.0510.0570.0490.0340.0350.0340.029
EBITDA 10.23510.23555.07655.07611.72355.74916.11535.248-2,152.11211.1972,095.44945.10267.51517.97720.62146.97461.32341.999-36.33961.662210.18181.82471.55482.6270.29874.14858.91652.38369.26792.84583.29360.21266.21668.20636.57543.6367.67260.14951.56451.2245.57545.12948.85538.08634.30536.06934.84228.98832.3427.8119.18119.06918.63313.758
EBITDA Ratio 0.0380.0380.2150.2150.060.1440.050.109-6.8590.036.9640.1590.2090.0530.0730.1720.2010.137-0.1120.2180.7760.2730.250.2930.2720.270.2370.2320.30.3730.3720.2670.3120.2940.1480.1890.2550.2440.2180.2480.2470.2540.2620.2570.2350.2730.2390.2640.2490.2640.2110.2590.3070.316